\
&
Contact us
\
&
Contact us
This was 1 year ago
LocationHybrid
The European Commission is organising a showcase event in Brussels on ‘Fostering synergies to beat cancer: The impact of EU-funded projects’. This will be an occasion to mark the World Cancer Day and demonstrate the impact of various EU grants & tenders in relation to the Europe’s Beating Cancer Plan and the Cancer Mission.
This event will bring together representatives of EU-funded cancer projects, NGOs, health organisations working in the field of cancer, National Contact Points and National Focal Points and policy makers.
The event will be held in person and online. More information, the detailed agenda and registration on the event website. Deadline to register is 28 January.
We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).
Stay informed about what matters to you.
By signing up, you can opt in for e-mail notifications and get access to
a personalised dashboard that groups all news updates and event announcements in your domain(s).
Only for stakeholders located in Flanders
The METHYLOMIC project, ‘targeting hope for personalised medicine in immune-mediated inflammatory diseases’ obtained funding from Horizon Europe’s Health Cluster. The project aims to personalise treatment allocation and enhance the effectiveness of medications for chronic immune-mediated diseases such as Crohn’s disease, rheumatoid arthritis, and psoriasis. BIRD, the Belgian inflammatory bowel disease research and development group, is a partner in the project and is involved in the OmiCrohn trial, a prospective randomised clinical trial for individualised therapy in Crohn’s disease patients. With BIRD’s active role in this trial, the project is set to deliver predictive, biomarker-based therapies that bring renewed hope for Crohn’s disease patients across Europe.
